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Abstract
Background:  The  aim  of  this  study  was  to  assess  the  nosocomial  transmission  of
methicillin-resistant  Staphylococcus  aureus  (MRSA)  and  the  predictive  role  of  colo-
nization  pressure  (CP)  in  a  low-prevalence  healthcare  setting.
Methods:  A  retrospective  analysis  of  MRSA  infection  rates  from  2004  to  2009  at  the
Saudi  Aramco  Dhahran  Health  Center,  Saudi  Arabia,  was  performed.  MRSA  patient-
days,  susceptible  patient-days,  nosocomial  incidence  and  CP  were  calculated  for
each  month  from  January  2008  to  December  2009.
Results:  During  the  study  period,  878  cases  of  MRSA  colonization/infection  were
identiﬁed.  Of  these  cases,  777  (88.4%)  and  101  (11.5%)  were  community-acquired
MRSA  (CA-MRSA)  and  healthcare-associated  MRSA  (HA-MRSA)  cases,  respectively.  A
decrease  in  the  number  of  HA-MRSA  cases  and  an  increase  in  the  number  of  CA-
MRSA  cases  were  observed  during  the  study  period.  The  incidence  of  nosocomial
infection  per  1000  susceptible  patient-days  was  1.17  in  2008  and  0.7  in  2009.  The
monthly  colonization  pressure  ranged  from  0.1  to  1.62  throughout  the  2-year  period.
Nosocomial  transmission  was  observed  in  13  months  of  the  24-month  study  period.  No
association  between  the  CP  of  the  preceding  month  and  the  incidence  of  nosocomial
transmission  in  the  subsequent  month  was  observed.
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Conclusion:  In  a setting  of  low  MRSA  prevalence,  CP  does  not  appear  to  be  a  useful
predictor  of  nosocomial  transmission  or  incidence.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
p
w
m
w
i
r
w
t
p
t
w
b
c
a
w
p
s
p
n
a
a
i
M
M
t
H
ﬁ
u
(
M
M
G
M
c
H
the detection  of  MRSA  infection  in  a  patient  who
had been  hospitalized  for  more  than  48  h  without
any indication  of  MRSA  infection  or  colonization©  2012  King  Saud  Bin  Ab
Ltd.  All  rights  reserved.
Introduction
Methicillin-resistant  Staphylococcus  aureus  (MRSA)
infection  has  become  endemic  in  many  hospi-
tals worldwide.  These  infections  are  associated
with increased  mortality,  morbidity  and  health
care costs  [1].  Colonized  or  infected  patients  are
the reservoir  of  infection,  and  patient-to-patient
transmission  is  facilitated  by  health  care  per-
sonnel, fomites  and  environmental  contamination
[2,3]. Several  preventative  protocols,  including
surveillance measures,  hand  hygiene,  and  decolo-
nization  using  chlorhexidine  body  washes  and  nasal
mupirocin,  have  been  adopted  with  varying  degrees
of success  [2,4,5].  Recent  studies  analyzed  colo-
nization  pressure  (CP)  as  an  independent  predictor
of nosocomial  acquisition  of  MRSA  [6—8].  However,
these studies  were  performed  in  settings  with  high
prevalence  rates  of  MRSA.  Currently,  there  are  no
reports on  CP  as  an  indicator  of  nosocomial  trans-
mission  of  MRSA  in  a  low-prevalence  setting.  In  this
paper, we  present  data  on  the  trends  in  MRSA  infec-
tion and  transmission  in  a  secondary  care  hospital  in
Saudi Arabia  and  on  the  utility  of  CP  as  a  predictor
of nosocomial  transmission  of  MRSA.
Materials and methods
Setting
This  study  was  performed  at  the  Saudi  Aramco
Dhahran Health  Center,  Saudi  Arabia.  This  405-bed
health  care  facility  is  comprised  of  inpatient  wards,
critical  care  units  and  outpatient  clinics.  It  provides
primary  and  secondary  care  to  a  catchment  popu-
lation of  360,000.  A  retrospective  analysis  of  MRSA
colonization/infection  in  inpatients  was  performed
over a  six-year  period  (2004—2009).
MRSA infection control policyAfter  a  patient  was  admitted,  MRSA  screening  was
performed  within  48  h.  Screening  swabs  of  the  ante-
rior nares,  wounds  and  sites  that  were  previously
u
c
tositive  for  MRSA  (in  known  MRSA-positive  patients)
ere obtained.  Isolation  and  contact  precaution
easures for  suspected  MRSA  patients  (‘‘at  risk’’)
ere implemented  upon  admission  and  remained
n place  until  screening  results  were  available.  At-
isk patients  were  deﬁned  as  those  patients  who
ere transferred  from  other  health  care  facili-
ies, had  a  history  of  hospitalization  within  the
ast year,  and  were  receiving  home  or  institu-
ional care.  A  policy  of  ‘‘once  MRSA  always  MRSA’’
as adopted  for  patients  who  were  known  to
e positive  for  MRSA  infection,  and  appropriate
ontrol measures  were  initiated  upon  subsequent
dmissions. Standard  infection  control  protocols
ere  adopted  for  all  MRSA-colonized  or  -infected
atients. MRSA-infected  patients  were  placed  in  a
ingle, private  room  or  with  other  MRSA-positive
atients. Contact  precautions,  including  the  don-
ing of  gloves/gowns  and  hand  hygiene  using
lcohol-based hand  rubs/soap  and  water,  were
dopted  by  all  staff  who  were  caring  for  any  MRSA-
nfected  patients.
RSA identiﬁcation
RSA  culture  was  performed  by  utilizing  conven-
ional screening  culture  methods  that  used  Mueller
inton  agar  (MHA)  with  4%  NaCl  and  oxacillin.  Con-
rmation  of  the  MRSA  phenotype  was  performed
sing MHA  with  a cefoxitin  disc  and  using  the  Vitek2
WSVT2-ROS.02)  automated  system  (bioMerieux,
arcy l’Etoile,  France).  Molecular  detection  of
RSA from  nasal  swab  samples  was  performed  using
eneXpert® (Cepheid,  Sunnyvale,  CA,  USA).
RSA deﬁnition and calculation of
olonization pressure
ospital-acquired  MRSA  (HA-MRSA)  was  deﬁned  aspon admission  to  the  hospital.  Patients  with  MRSA
olonization  or  infection  upon  admission  and  a his-
ory of  hospitalization  within  the  past  30  days  were
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Fig.  2  Specimen  sources  of  MRSA  isolates.
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lso  considered  to  have  HA-MRSA.  All  other  infected
atients  were  classiﬁed  as  being  infected  with
ommunity-acquired  MRSA  (CA-MRSA)  [9].  MRSA
atient-days,  susceptible  patient-days,  nosocomial
ncidence  and  CP  were  calculated  for  each  month
rom  January  2008  to  December  2009  as  previously
escribed [8].  The  calculation  of  MRSA  patient-
ays included  MRSA-positive  patients  who  were
reviously  known  and  newly  identiﬁed,  nosocomial
ases as  previously  described.  The  number  of  sus-
eptible patient-days  was  calculated  as  the  total
umber of  patient-days  minus  the  number  of  MRSA
atient-days  [8].  CP  was  calculated  as  the  num-
er of  MRSA  patient-days  ×  100/the  total  number  of
atient-days.  Nosocomial  incidence  was  calculated
s the  number  of  new,  nosocomial  cases  ×  1000/the
umber of  susceptible  patient-days  [8].  The  pres-
nce or  absence  of  MRSA  transmission  in  the  month
mmediately  following  each  month  for  which  CP
as calculated  was  also  determined.  CP  was  used
o predict  the  nosocomial  acquisition  of  MRSA
nfection and  colonization.  Statistical  analysis  was
erformed using  Graphpad  Prism  software  (La  Jolla,
A, USA).
esults
 total  of  878  cases  of  MRSA  colonization/infection
ere  identiﬁed.  Of  these  cases,  777  (88.4%)  and  101
11.5%) were  CA-MRSA  and  HA-MRSA  cases,  respec-
ively.  A  decrease  in  the  number  of  HA-MRSA  cases
nd an  increase  in  the  number  of  CA-MRSA  cases
as observed  during  the  study  period  (Fig.  1).  In
008, 10  cases  of  HA-MRSA  were  identiﬁed,  and  the
umber of  cases  reported  decreased  to  six  in  2009.
he majority  of  HA-MRSA  isolates  were  detected
n patients  with  bacteremia  or  with  surgical  wound
nfections  (Fig.  2).
F
2The  total  numbers  of  patient-days  were  103,086
nd 104,410  in  2008  and  2009,  respectively.  The
umber  of  MRSA  patient-days  was  954  in  2008  and
06 in  2009.  The  incidence  of  nosocomial  infec-
ion per  1,000  susceptible  patient-days  was  1.17
n 2008  and  0.7  in  2009.  The  monthly  coloniza-
ion pressure  ranged  from  0.1  to  1.62%  during  the
wo-year study  period.  The  monthly  distribution  of
osocomial  MRSA  acquisition  and  the  colonization
ressure are  shown  in  Fig.  3.  Nosocomial  transmis-
ion was  observed  in  13  months  of  the  24-month
tudy period.  However,  no  association  between  the
P in  the  preceding  month  and  the  nosocomial  inci-
ence in  the  subsequent  month  was  observed.  In
he last  six  months  of  2009,  a sustained  level  of
osocomial  transmission  was  observed  despite  a
teady decline  in  the  monthly  colonization  pres-
ure. During  the  two-year  study  period,  there  was
o outbreak  of  MRSA  infection  at  the  facility.ig.  3  Colonization  pressure  and  nosocomial  incidence
008—2009.
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Discussion
Globally,  MRSA  continues  to  be  a  major  cause  of
nosocomial  infection.  In  this  study,  we  evaluated
the occurrence  of  HA-MRSA  in  our  institution  and
found that  there  was  a  decrease  in  the  number
of observed  cases  from  2005  to  2009.  An  increase
in the  number  of  CA-MRSA  cases  during  the  study
period suggests  that  CA-MRSA  is  an  emerging,  signif-
icant cause  of  infection  in  the  healthcare  setting.  In
the literature,  the  distribution  of  MRSA  infection  is
signiﬁcantly  variable  by  geographical  location.  Even
within the  same  country,  variations  in  the  incidence
of MRSA  infection  have  been  observed  between
different health  care  facilities/units.  Surveillance
data demonstrated  a  north:south  dichotomy  of
MRSA incidence  in  Europe;  speciﬁcally,  a  larger
prevalence  of  MRSA  was  observed  to  occur  in  south-
ern European  countries  compared  with  northern
European countries  [10].  While  a  decreasing  trend
in the  number  of  HA-MRSA  infections  was  reported
in 2008,  the  incidence  of  MRSA  is  still  >25%  in
one-third of  the  European  countries.  In  the  United
States,  up  to  46%  of  the  staphylococci  isolates  from
non-intensive  care  units  and  over  50%  of  those  from
ICUs were  determined  to  be  MRSA  isolates  [11,12].
In Saudi  Arabia,  a  MRSA  infection  rate  of  38%  was
reported  previously  in  a  tertiary  care  center  in  Jed-
dah, and  a  range  of  MRSA  infection  rates  from  12
to 49%  was  demonstrated  in  several  hospitals  in
Riyadh [13,14].  At  our  institution,  the  MRSA  con-
trol policy  includes  screening  patients  within  48  h
of admission,  providing  of  single  room  to  infected
patients or  rooming  MRSA-colonized  or  infected
patients together  and  strictly  enforcing  contact
precautions. In  addition,  a  policy  of  ‘‘once  MRSA
always  MRSA’’  is  implemented  for  patients  who
have been  infected,  which  enables  staff  to  immedi-
ately  institute  appropriate  preventative  measures
upon  subsequent  admissions.  The  implementation
of these  policies  can  explain  the  decrease  in  the
number  of  nosocomially  transmitted  MRSA  cases
during  the  study  period  even  when  there  was  an
increase  in  the  numbers  of  patients  being  admitted
with CA-MRSA.  While  the  implementation  of  these
policies  can  be  challenging  in  some  settings,  these
ﬁndings  indicate  that  adherence  to  this  preventa-
tive regimen  is  associated  with  a  reduction  in  the
occurrence  of  HA-MRSA.
In  addition  to  control  measures,  indicators  of
nosocomial  MRSA  infections  have  been  suggested
for use  as  predictors  of  possible  outbreaks.  CP
has been  proposed  as  an  indicator  of  nosocomial
transmission of  antibiotic-resistant  bacteria,  such
as MRSA,  vancomycin-resistant  enterococci  (VRE)
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nd  Clostridium  difﬁcile  infection  [7,15,16]. The
se of  this  indicator  is  predicated  on  the  idea
hat CP  increases  both  the  possibility  of  contact
etween health  care  workers  and  infected  patients
nd environmental  contamination  in  the  health-
are setting,  thus  resulting  in  a higher  transmission
otential. It  can  be  hypothesized  that  when  the
P is  high,  the  reservoir  of  infection  is  large.
herefore, even  minor  lapses  in  infection  con-
rol protocols  are  likely  to  result  in  nosocomial
ransmission  and  the  potential  for  MRSA  outbreaks.
owever, the  CP  levels  for  which  this  hypothesis
olds true  are  unclear.  Previous  work  that  assessed
P as  a  predictor  of  nosocomial  MRSA  transmis-
ion was  carried  out  in  an  intensive  care  unit  and
 general  medical  unit  [7,8].  In  these  studies,  the
revalence  of  nosocomial  MRSA  infection  and  the
P were  much  higher  compared  with  the  rates  that
e found  in  this  study.  Using  multivariate  regres-
ion analysis,  Merrer  et  al.  [7]  demonstrated  that
P was  strongly  and  independently  associated  with
RSA acquisition  in  the  ICU.  Similarly,  Bonten  et  al.
16] demonstrated  that  colonization  pressure  was
he main  variable  that  affected  the  acquisition  of
RE. Recently,  it  was  suggested  that  C.  difﬁcile-
ssociated  disease  pressure  (which  is  a  modiﬁed
orm of  CP)  could  be  an  independent  risk  factor
or C.  difﬁcile-associated  diseases  [15].  However,
n settings  of  sporadic  C.  difﬁcile  infections,  CP
as not  associated  with  the  acquisition  of  C.  dif-
cile in  approximately  one-third  of  the  patients
17]. In  contrast  to  the  previously  reported  data
hat were  gathered  from  a high  CP  setting  [8],
e did  not  observe  any  correlation  between  the
P levels  and  nosocomial  incidence  of  MRSA  infec-
ion. This  result  suggests  that  in  settings  of  low
RSA prevalence,  CP  may  not  be  a reliable  predic-
or of  MRSA  transmission  and  nosocomial  infection.
owever, our  ﬁndings  indicate  that  nosocomial
ransmission  of  MRSA  does  occur  in  cases  of  low
P. This  is  most  likely  because  the  transmission  of
RSA between  patients,  particularly  transmission
ia health  care  personnel  and  environmental  con-
amination,  is  likely  to  occur  whenever  there  are
apses in  the  implementation  of  infection  control
olicies.  Although  the  impact  of  such  lapses  is  likely
o be  magniﬁed  when  the  CP  level  is  high,  thus
eading to  outbreaks,  other  factors,  such  as  stafﬁng
evels, have  been  demonstrated  to  be  important
7,18]. Following  the  institution’s  MRSA  control  pol-
cy, MRSA  screening  was  carried  out  within  48  h  afterRSA’’  policy  was  adopted  for  patients  who  were
nown or  had  been  known  to  be  MRSA-positive  and
ll MRSA  patients  were  placed  in  single  rooms  or
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[
ﬁeld JL, McDonald LC, et al. Evaluation of Clostridium
difﬁcile-associated disease pressure as a risk factor for C
difﬁcile-associated disease. Archives of Internal Medicineethicillin-resistant  Staphylococcus  aureus  transmi
ere  roomed  with  other  MRSA-infected  individuals
uring the  study  period.  While  we  did  not  mea-
ure the  rate  of  compliance  with  other  infection
ontrol procedures,  such  as  hand  hygiene  and  con-
act precautions,  we  speculate  that  compliance  was
igh, as  evidenced  by  the  steady  decline  in  MRSA
ates  that  was  observed  during  the  study  period.
owever, the  observed,  ongoing  nosocomial  MRSA
ransmission  in  combination  with  the  declining  CP
ates in  the  last  few  months  of  2009  is  suggestive
f lapses  in  compliance.  We  suggest  that,  in  low
RSA prevalence  and  low  CP  settings,  particular
ttention should  be  paid  to  ensuring  strict  adher-
nce to  infection  control  policies.  Some  potential
imitations of  this  study  are  that  it  was  a  single-
enter study  and  clonality  investigations  were  not
erformed.  Multi-center  studies  in  settings  with  a
ow MRSA  prevalence  are  needed  to  conﬁrm  the  role
f CP  as  a  predictor  of  noscomomial  MRSA  transmis-
ion.
In conclusion,  we  have  demonstrated  a  low  MRSA
revalence  and  a  decrease  in  the  rate  of  nosocomial
RSA transmission  in  a  secondary  care  facility  in
audi Arabia.  Further  studies  are  needed  to  deﬁne
he utility  of  CP  as  a  predictor  of  nosocomial  MRSA
ransmission  and  incidence  in  settings  with  a  low
revalence  of  MRSA  infection.
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